These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 15069988)

  • 21. [Fully possible to reduce the costs of hypertension treatment].
    Wettermark B; Angman A; Hjemdahl P
    Lakartidningen; 2009 Jun 3-9; 106(23):1558-62. PubMed ID: 19583013
    [No Abstract]   [Full Text] [Related]  

  • 22. Cost-minimization and the number needed to treat in uncomplicated hypertension.
    Pearce KA; Furberg CD; Psaty BM; Kirk J
    Am J Hypertens; 1998 May; 11(5):618-29. PubMed ID: 9633802
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cost-minimization analysis of initial antihypertensive therapy in patients with mild-to-moderate essential diastolic hypertension.
    Hilleman DE; Mohiuddin SM; Lucas BD; Stading JA; Stoysich AM; Ryschon K
    Clin Ther; 1994; 16(1):88-102; discussion 87. PubMed ID: 7911403
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Compliance with antihypertensive therapy in the elderly: a comparison of fixed-dose combination amlodipine/benazepril versus component-based free-combination therapy.
    Dickson M; Plauschinat CA
    Am J Cardiovasc Drugs; 2008; 8(1):45-50. PubMed ID: 18303937
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Changes in the costs of antihypertensive medications in a developing country: a study in Mexico comparing 1990 and 1996.
    Calvo-Vargas CG; Parra Carrillo JZ; Grover Páez F; Fonseca Reyes S
    Am J Hypertens; 1998 Apr; 11(4 Pt 1):487-93. PubMed ID: 9607388
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pricing and reimbursement of pharmaceuticals in the Czech Republic and Sweden.
    Davidova J; Praznovcova L; Lundborg CS
    Pharm World Sci; 2008 Jan; 30(1):57-64. PubMed ID: 17588212
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antihypertensive Drugs in Croatia: What Changes the Drug Usage Patterns?
    Kucan M; Mrsic-Pelcic J; Vitezic D
    Clin Ther; 2018 Jul; 40(7):1159-1169. PubMed ID: 30017168
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Trends in pharmacologic management of hypertension in the United States.
    Manolio TA; Cutler JA; Furberg CD; Psaty BM; Whelton PK; Applegate WB
    Arch Intern Med; 1995 Apr; 155(8):829-37. PubMed ID: 7717791
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Therapy of hypertension. Cost conscious prevention of complications].
    Kolloch RE
    MMW Fortschr Med; 2003 Nov; 145(47):64. PubMed ID: 14725042
    [No Abstract]   [Full Text] [Related]  

  • 30. Shifting trends in the pharmacologic treatment of hypertension in a Nigerian tertiary hospital: a real-world evaluation of the efficacy, safety, rationality and pharmaco-economics of old and newer antihypertensive drugs.
    Adigun AQ; Ishola DA; Akintomide AO; Ajayi AA
    J Hum Hypertens; 2003 Apr; 17(4):277-85. PubMed ID: 12714973
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of combination therapy on managed care. Based on a presentation by Lisa Latts, MD, MSPH.
    Am J Manag Care; 1999 Jun; 5(7 Suppl):S456-60; discussion S460-2. PubMed ID: 10538854
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The High Cost of Prescription Drugs in the United States: Origins and Prospects for Reform.
    Kesselheim AS; Avorn J; Sarpatwari A
    JAMA; 2016 Aug 23-30; 316(8):858-71. PubMed ID: 27552619
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of real-world adherence, healthcare resource utilization and costs for newly initiated valsartan/amlodipine single-pill combination versus angiotensin receptor blocker/calcium channel blocker free-combination therapy.
    Baser O; Andrews LM; Wang L; Xie L
    J Med Econ; 2011; 14(5):576-83. PubMed ID: 21728914
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Patterns of persistence with antihypertensive medications in newly diagnosed hypertensive patients in Italy: a retrospective cohort study in primary care.
    Mazzaglia G; Mantovani LG; Sturkenboom MC; Filippi A; Trifirò G; Cricelli C; Brignoli O; Caputi AP
    J Hypertens; 2005 Nov; 23(11):2093-100. PubMed ID: 16208153
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The potential savings of using thiazides as the first choice antihypertensive drug: cost-minimisation analysis.
    Fretheim A; Aaserud M; Oxman AD
    BMC Health Serv Res; 2003 Sep; 3(1):18. PubMed ID: 12959644
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treating essential hypertension. The first choice is usually a thiazide diuretic.
    Prescrire Int; 2014 Sep; 23(152):215-20. PubMed ID: 25325125
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association between cardiovascular outcomes and antihypertensive drug treatment in older women.
    Wassertheil-Smoller S; Psaty B; Greenland P; Oberman A; Kotchen T; Mouton C; Black H; Aragaki A; Trevisan M
    JAMA; 2004 Dec; 292(23):2849-59. PubMed ID: 15598916
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antihypertensive treatment with and without benazepril in patients with chronic renal insufficiency: a US economic evaluation.
    Hogan TJ; Elliott WJ; Seto AH; Bakris GL
    Pharmacoeconomics; 2002; 20(1):37-47. PubMed ID: 11817991
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pricing in the NHS.
    Ellwood S
    Br J Hosp Med; 1996 Sep 18-Oct 1; 56(6):299-301. PubMed ID: 8889106
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Medical therapy cost considerations for glaucoma.
    Fiscella RG; Green A; Patuszynski DH; Wilensky J
    Am J Ophthalmol; 2003 Jul; 136(1):18-25. PubMed ID: 12834665
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.